You just finished a Q-bank question on “autoimmune mechanism overview,” got the answer right (nice), and moved on… but Step-style questions are designed so that every answer choice is a mini-lesson. If you can explain why each distractor is wrong—and what condition it would match—you’re not just learning facts; you’re building pattern recognition for test day.
Tag: Immunology > Transplant & Autoimmune
The Clinical Vignette (Step-Style)
A 29-year-old woman presents with fatigue, joint pain, and a facial rash that worsens with sun exposure. She reports painless oral ulcers. Exam shows a malar rash and mild swelling of the PIP joints. Labs reveal:
- ANA positive
- Anti–double-stranded DNA positive
- Low complement (C3/C4)
- Urinalysis: proteinuria and RBC casts
Renal biopsy shows granular deposits of IgG and C3 along the glomerular basement membrane on immunofluorescence.
Question: Which immunologic mechanism best explains her renal disease?
Answer choices
A. Type II hypersensitivity with antibodies against a fixed basement membrane antigen
B. Type III hypersensitivity from circulating immune complex deposition
C. Type IV hypersensitivity due to cytotoxic T-cell–mediated injury
D. Autoantibodies against the acetylcholine receptor causing receptor blockade
E. Autoantibodies against desmoglein causing loss of keratinocyte adhesion
Correct Answer: B. Type III hypersensitivity (immune complex deposition)
This is classic SLE with lupus nephritis.
Why Type III fits perfectly
- Autoantibodies (especially anti-dsDNA) bind soluble antigens → circulating immune complexes
- Complexes deposit in tissues with filtration/high pressure (kidney glomeruli, joints, skin)
- Complement activation → inflammation → tissue injury
- Low complement (consumption) is a huge clue
The “granular vs linear” clue (must-know)
| Condition | Mechanism | IF pattern |
|---|---|---|
| Lupus nephritis | Type III immune complex deposition | Granular (“lumpy-bumpy”) |
| Goodpasture syndrome | Type II anti-GBM antibodies | Linear |
High-yield pearl: In SLE, anti-dsDNA correlates with lupus nephritis, and anti-Smith is highly specific (but not correlated with activity).
Why Every Other Answer Choice Is Wrong (and What It Actually Describes)
A. Type II hypersensitivity with antibodies against a fixed basement membrane antigen
This sounds close because the kidney is involved—but the mechanism is different.
What it describes: Goodpasture syndrome
- Autoantibodies against type IV collagen in GBM (and alveolar BM)
- Presents with hematuria + hemoptysis
- Linear deposition of IgG/C3 on IF
Why it’s wrong here
- Patient has SLE markers (anti-dsDNA, low complement, systemic symptoms)
- IF is granular, not linear
USMLE trigger: Pulmonary hemorrhage + rapidly progressive GN + linear IF = Goodpasture.
C. Type IV hypersensitivity due to cytotoxic T-cell–mediated injury
Type IV is T-cell mediated, not antibody/complement driven.
What it describes (high-yield examples):
- Type 1 diabetes (CD8+ T-cell destruction of β cells)
- Multiple sclerosis (T-cell mediated CNS demyelination)
- Contact dermatitis (poison ivy; delayed hypersensitivity)
- TB skin test (PPD) and granulomatous inflammation
Why it’s wrong here
- This vignette screams immune complexes: low complement + granular deposits
- Lupus nephritis is not primarily cytotoxic T-cell injury
Step tip: If you see low complement, think antibody/complement consumption → often Type III (SLE, PSGN, cryoglobulinemia).
D. Autoantibodies against the acetylcholine receptor causing receptor blockade
That’s a beautiful distractor for antibody-mediated disease—but it’s the wrong autoimmune target and clinical picture.
What it describes: Myasthenia gravis (Type II)
- Autoantibodies to postsynaptic ACh receptors at NMJ
- Fluctuating weakness, ptosis, diplopia
- Improves with rest; worsens with use
- Associated with thymic hyperplasia/thymoma
Why it’s wrong here
- No fatigable weakness or ocular findings
- Renal immune complex nephritis doesn’t fit receptor blockade at NMJ
High-yield: MG = antibodies block receptors (decreased functional receptors).
E. Autoantibodies against desmoglein causing loss of keratinocyte adhesion
Another Type II antibody-mediated disease—just not the one in the vignette.
What it describes: Pemphigus vulgaris
- IgG against desmoglein (desmosomes)
- Flaccid bullae, mucosal involvement common
- +Nikolsky sign (skin sloughing with pressure)
- Histology: acantholysis (“row of tombstones”)
Why it’s wrong here
- Patient has malar rash, arthritis, nephritis—not blistering disease
- Kidney pathology points to immune complexes
USMLE contrast:
- Pemphigus vulgaris = intraepidermal, flaccid bullae, mucosa.
- Bullous pemphigoid (another classic) = anti-hemidesmosomes → subepidermal, tense bullae.
The Big Picture: Autoimmunity Mechanisms You Must Own
Hypersensitivity mapping (high-yield table)
| Type | Mediator | Key mechanism | Classic examples |
|---|---|---|---|
| I | IgE, mast cells | Immediate; histamine, leukotrienes | Anaphylaxis, asthma, allergic rhinitis |
| II | IgG/IgM vs fixed antigen | Opsonization, complement, receptor blockade/activation | AIHA, ITP, Goodpasture, Graves, MG, pemphigus |
| III | Immune complexes | Deposition → complement activation → inflammation | SLE, PSGN, serum sickness, cryoglobulinemia |
| IV | T cells (Th1/Th17/CD8) | Delayed; macrophage activation/cytotoxicity | Contact dermatitis, T1DM, MS, TB granulomas |
“Granular deposits + low complement” shortcut
If a stem gives you:
- granular IF
- hypocomplementemia
- signs of systemic inflammation (rash, arthritis)
→ think Type III immune complex disease until proven otherwise.
Quick Transplant Tie-In (Because Step Loves Cross-Topic Integration)
Autoimmune pathology and transplant rejection both use the same immunology vocabulary—but the timelines and effectors differ.
| Process | Primary mechanism | Timing | Key buzzwords |
|---|---|---|---|
| Hyperacute rejection | Preformed anti-donor antibodies (Type II-like) | Minutes–hours | Thrombosis, necrosis, crossmatch positive |
| Acute rejection | T cells ± antibodies | Days–weeks (or later if immunosuppression low) | Endothelitis, tubulitis; treat with steroids |
| Chronic rejection | T-cell cytokines → smooth muscle proliferation, fibrosis | Months–years | Graft vascular narrowing, interstitial fibrosis |
Testable bridge: Antibody-mediated phenomena can show up in both autoimmunity (e.g., Goodpasture, SLE) and transplant rejection (hyperacute/antibody-mediated acute rejection). The trick is recognizing pattern + time course + pathology.
Takeaway: Turn Distractors Into Diagnoses
When you see immune-mediated pathology, force yourself to answer two questions:
- Is it antibody or T-cell mediated?
- If antibody-mediated: is it Type II (fixed target) or Type III (immune complexes)?
In this vignette: anti-dsDNA + low complement + granular IF + nephritic/nephrotic signs = Type III (SLE immune complex nephritis).